Some PD genes, including PARK1/4, PINK1, and PARK9 (ATP13A2), have already been detected to be associated with brain tumors, indicating that the same mutations can lead to pathological changes in both PD and brain tumors [27,50]. This evidence concerns the gene SNCA and Parkinson disease.